Integumen in talks about potentially buying data analytics and biophysics firms

Healthcare company Integumen is in talks about the potential acquisition of data analytics, software and biophysics companies.

Integumen, which has developed an artificial skin for testing in labs instead of using animal skin, is looking at investing in a number of other areas to boost its business, it said last week.

The company is backed by Gerard Brandon who set up the wound-care firm Alltracel, and his business partner Tony Richardson.

Last August ...